» Articles » PMID: 21762248

Breast Cancer Risk in Relation to Alcohol Consumption and BRCA Gene Mutations--a Case-only Study of Gene-environment Interaction

Overview
Journal Breast J
Publisher Wiley
Date 2011 Jul 19
PMID 21762248
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The variable penetrance of the BRCA1 and BRCA2 genes suggests that other genetic or environmental factors may interact with these mutations to modify breast cancer risk. The objective of this study was to measure departures from multiplicative effects of alcohol consumption and BRCA gene mutations. A cohort of French-Canadian breast cancer patients was tested for BRCA gene mutations and completed a food frequency questionnaire. The case-only odds ratio (COR) was calculated. A total of 857 women, including 10 BRCA1 and 33 BRCA2 mutation carriers, participated in the study. No significant interaction between alcohol consumption and BRCA1 mutations was detected, although the interaction with wine consumption suggested a sub-multiplicative effect (COR = 0.38, 95% CI: 0.08-1.81). Consumption of alcohol other than wine interacted significantly with BRCA2 mutations (COR = 2.15, 95% CI: 1.03-4.49). Consumption of wine may protect against BRCA1-associated tumors, while women with BRCA2 mutations may be at greater risk of alcohol-induced breast cancer.

Citing Articles

Influence of alcohol consumption and alcohol metabolism variants on breast cancer risk among Black women: results from the AMBER consortium.

Young K, Olshan A, Lunetta K, Graff M, Williams L, Yao S Breast Cancer Res. 2023; 25(1):66.

PMID: 37308906 PMC: 10259046. DOI: 10.1186/s13058-023-01660-1.


Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review.

Daniele A, Divella R, Pilato B, Tommasi S, Pasanisi P, Patruno M Hered Cancer Clin Pract. 2021; 19(1):45.

PMID: 34706754 PMC: 8554866. DOI: 10.1186/s13053-021-00199-6.


Diet, weight management, physical activity and Ovarian & Breast Cancer Risk in women with pathogenic Germline gene variants: systematic review.

Coletta A, Peterson S, Gatus L, Krause K, Schembre S, Gilchrist S Hered Cancer Clin Pract. 2020; 18:5.

PMID: 32165993 PMC: 7060535. DOI: 10.1186/s13053-020-0137-1.


Mutations and Breast Cancer Prevention.

Kotsopoulos J Cancers (Basel). 2018; 10(12).

PMID: 30572612 PMC: 6315560. DOI: 10.3390/cancers10120524.


Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.

Iyer P, Karthikeyan S, Sanjay Kumar P, Namboori P Funct Integr Genomics. 2017; 17(4):375-385.

PMID: 28470340 DOI: 10.1007/s10142-017-0559-7.